1Mcgarry J D. Banting Lecture 2001. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes [J]. Diabetes, 2002,51 (1): 7-18.
2Baltali M, Gokcel A, Kiziltan H T, et al. Association between the metabolic syndrome and newly diagnosed coronary artery disease [J]. Diabetes Nutr Metab,2003, 16(3) :169-175.
3Boden G. Free fatty acids as target for therapy[J]. Curr Opin Endocrinol Diab, 2004,11 (5) : 258-263.
4Hickman I J, Whitehead JP, Prins JB, et al. Raised atanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes [J]. Diabetes Obes Metab, 2007,9 (3): 438- 440.
6Yu ZF, Bruce-Keller AJ, Goodman Y, et al. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and aginst focal ischemic brain injury in vivo[J]. J Neurosci Res, 1998, 53 (5) : 613-625.
7Glantzounis G K, Tsimoyiannis E C, Kappas A M, et al. Uric acid and oxidative stress[J]. Current Pharmaceutical Design, 2005, 11 (32) : 4145-4151.
8Ishii H, Kurose I, Kato S. Pathogenesis of alcoholic liver disease with particular emphasis on oxidative stress [J]. Journal of Gastroenterology and Hepatology, 1997:12 (9-10) : $272-$282.
